TO EVAUATE THE EFFECT OF INDIVIDUALISED HOMOEOPATHIC TREATMENT IN PATIENTS OF ATOPIC DERMATITIS ASSOCIATED WITH GENERALISED ANXIETY
- Conditions
- Health Condition 1: L209- Atopic dermatitis, unspecified
- Registration Number
- CTRI/2024/05/067535
- Lead Sponsor
- ational Institute of Homoeopathy, Kolkata
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Patients of Atopic dermatitis fulfilling Hanifin and Rajka diagnostic criteria associated with generalised anxiety (having GAD-7 score of more than or equal to 10).
Patient age group 18-60 years, of any gender, of any religion, of any socio-economic background.
Patents must be knowing either Hindi or English or Bengali.
Patients willing to give written informed consent.
Patients already undergoing regular oral/topical conventional therapy for atopic dermatitis may be recruited only if the medications are stopped completely 3 months prior to the treatment.
Patient who are already taking medication for Generalised Anxiety for long term or to be decided as per the present general health of the patient.
Patient suffering from any life threatening/ Psychiatric/ illness or Immuno-compromised state or other significant disease condition.
Patients with malignancy of any organ.
Pregnant or lactating women.
Substance abuse and/or dependence.
Patients not willing to give consent for participation in the study.
Patients not willing to undergo any investigations if advised.
Patients who continue to be under other method of treatment or therapy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Eczema Area and Severity Index (EASI) score for atopic dermatitis. <br/ ><br>Generalised Anxiety Disorder (GAD-7) score for generalised anxietyTimepoint: At baseline and 6th month
- Secondary Outcome Measures
Name Time Method To ascertain and shortlist the most frequently indicated Homoeopathic medicines in the treatment of patients of atopic dermatitis associated with generalised anxiety. <br/ ><br>To ascertain the predominant miasm in treatment of patients of atopic dermatitis associated with generalised anxiety. <br/ ><br>Timepoint: 6 months